Solid Tumour

Oncology
3
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
3
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Teva
TevaIsrael - Petach Tikva
1 program
1
CEP-37250/KHK2804Phase 11 trial
Active Trials
NCT01447732Completed71Est. Jan 2015
Kyowa Hakko Kirin
Kyowa Hakko KirinCA - La Jolla
1 program
1
CEP-37250/KHK2804Phase 1
Takeda
TakedaTOKYO, Japan
1 program
1
MVC-101Phase 11 trial
Active Trials
NCT04891718Withdrawn0Est. Jun 2022
Pfizer
PfizerNEW YORK, NY
1 program
Nivestim™ in Treatment of Malignant DiseasesN/A1 trial
Active Trials
NCT01627990Completed386Est. Dec 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
TakedaMVC-101
TevaCEP-37250/KHK2804
PfizerNivestim™ in Treatment of Malignant Diseases

Clinical Trials (3)

Total enrollment: 457 patients across 3 trials

NCT04891718TakedaMVC-101

CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia

Start: Sep 2021Est. completion: Jun 20220
Phase 1Withdrawn
NCT01447732TevaCEP-37250/KHK2804

Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors

Start: Oct 2011Est. completion: Jan 201571 patients
Phase 1Completed
NCT01627990PfizerNivestim™ in Treatment of Malignant Diseases

Nivestim™ in Treatment of Malignant Diseases

Start: Jun 2011Est. completion: Dec 2013386 patients
N/ACompleted

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
1h ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
1h ago

Office Administrator

SystImmune
1h ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
1h ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
2h ago

Working Student Active Sourcing Support (m/f/d)

Mindpeak
Hamburg
2h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)